Which drug companies agreed to lower prices after President Trump's announcement?

Nine drugmakers, including Amgen, Merck, and Novartis, agreed to lower their prescription drug prices.

When did President Trump announce the drug price reductions?

President Donald Trump announced the agreement on Friday, December 19.

What is the impact of the drugmakers' agreement on US consumers?

The agreement aims to lower the cost of prescription drugs, providing financial relief to US consumers.

Home / Business and Economy / Drugmakers Cut Prices After Trump Deal

Drugmakers Cut Prices After Trump Deal

20 Dec, 2025

•

Summary

Nine drugmakers agreed to lower prescription drug costs.
The agreement was announced by President Donald Trump on Friday.
The move aims to reduce the financial burden on US consumers.

US President Donald Trump announced on Friday, December 19, that a significant agreement has been reached with nine major pharmaceutical companies to lower prescription drug costs across the nation. This landmark deal involves companies including Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi.

The commitment from these leading drug manufacturers signifies a potential shift in pharmaceutical pricing strategies. The White House stated that these companies have agreed to curb the rising costs of their medications, aiming to provide financial relief to American patients. This initiative reflects an effort to make essential treatments more accessible.